Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID07145138

University of Illinois Chicago Multi-Ethnic Dilated Cardiomyopathy (DCM) Registry

Led by University of Illinois at Chicago · Updated on 2025-08-28

1500

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to understand how dilated cardiomyopathy (DCM), a serious heart condition where the heart cannot pump blood effectively, affects different racial and ethnic groups in the United States. The study focuses on minorities such as African American and Hispanic/Latino patients, who are more commonly affected and may experience more severe outcomes. Researchers want to find out if specific genes linked to DCM are more frequent in these groups and how medical, social, and financial challenges contribute to the disease's impact. Participants will join the UIC Multi-Ethnic DCM Biorepository, where their genetic information will be collected and analyzed to see how often certain gene variants appear across different races and ethnicities. The study will not involve treatments but will observe and record health data over time to assess the severity of DCM and its symptoms. The focus is on understanding how a person's environment and genetic background influence their heart condition. During the study, participants will provide consent and share health information, including completing questionnaires like the Minnesota Living with Heart Failure Questionnaire if they have or develop heart failure. Researchers will monitor genetic variants and symptom severity at multiple time points, such as 12, 24, and 60 months after enrollment or diagnosis. The study aims to help improve heart care equity by identifying factors that affect disease severity among ethnic minorities. Participation may last several years, with ongoing data collection and evaluation.

CONDITIONS

Brief Title

UIC Multi-Ethnic DCM Registry

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Must be at least 18 years of age and be admitted to or seen at a UIH site.
  • Must be willing and able to give written, informed consent.
Not Eligible

You will not qualify if you...

  • Adults who are unable to provide consent.
  • Women who are pregnant at the baseline visit.
  • Prisoners.
  • Individuals who are not yet adults (infants, children, teenagers).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Baseline

Participants undergo assessments to identify genetic variants and evaluate disease severity.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 60 months

Participants with heart failure or who develop heart failure complete digital symptom assessments over time.

Assessments at 12 months, 24 months, and 60 months after enrollment or new heart failure diagnosis

Trial Site Locations

Total: 1 location

1

University of Illinois Hospital & Health Sciences

Chicago, Illinois, United States, 60612

Actively Recruiting

Loading map...

Research Team

D

David Tofovic, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Extensive Post-discharge Counselling and Phone-based Follow-...

Heart Failure

Actively Recruiting

1 location

Three-Dimensional Assessment of Right Ventricular Function i...

Heart Failure

Actively Recruiting

1 location

Myocardial Fibrosis in Heart Failure: A Pilot Study Using 68...

Myocardial Fibrosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here